SCHEMBL6860743

SCHEMBL6860743

Oc1ccc(C2CNCCCN2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
KCNH2 Q12809 1/20 0.37
ESR2 Q92731 3/20 0.36
KDM1A O60341 2/20 0.36
ESR1 P03372 1/20 0.36
KDM4E B2RXH2 3/20 0.35
RECQL P46063 3/20 0.35
DRD1 P21728 2/20 0.35
BLM P54132 2/20 0.35
MEN1 O00255 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
NFKB1 P19838 1/20 0.35
CYP2C19 P33261 1/20 0.35
THPO P40225 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6131967 0.89 ESR2 (0.38) CYP2D6SLC6A2SLC6A4SLC6A3ESR2
Hydrochloric Acid SCHEMBL11553193 0.87 ESR2 (0.37) CYP2D6SLC6A2SLC6A4SLC6A3ESR2
SCHEMBL6865588 0.81 CYP2D6 (0.37) CYP2D6SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL9829845 0.81 KDM1A (0.41) CYP2D6KDM1AMEN1CYP2C9CYP2C19
SCHEMBL13187302 0.80 ESR2 (0.44) ESR2KDM1AESR1KDM4ERECQL
SCHEMBL8079160 0.80 ESR2 (0.44) ESR2KDM1AESR1KDM4ERECQL
SCHEMBL19580315 0.79 CHRNB2 (0.50) CYP2D6ESR2ESR1MEN1CYP2C9
SCHEMBL7970766 0.78 CYP2D6 (0.33) CYP2D6SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL28677309 0.78 SLC18A3 (0.42) CYP2D6KDM1AMEN1CYP2C9CYP2C19
SCHEMBL6868706 0.77 MAOA (0.50) SLC6A2SLC6A4SLC6A3KDM1AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825189-B1 TREATING WITHDRAWAL SYMPTOMS CAUSED BY SMOKING CESSATION NEUROSEARCH A/S (DK) 2004-11-30 US claimed
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed